JJ

Jignesh Jaysukhbhai Bhimani

Active Director Designated Partner DIN 11096537
DIN 11096537 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jignesh Jaysukhbhai Bhimani

Data last updated:

Jignesh Jaysukhbhai Bhimani is a Designated Partner at Narmada Life Line Multispeciality Hospital Llp (since 2025).

DIN 11096537
Primary Designation Designated Partner
First Appointment 21 May 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 May 20252024Active

Board colleagues of Jignesh Jaysukhbhai Bhimani

Directorship timeline

Open interactive timeline →
Narmada Life Line Multispeciality Hospital Llp
Premium access

Shareholding and investment profile for Jignesh Jaysukhbhai Bhimani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jignesh Jaysukhbhai Bhimani

Jignesh Jaysukhbhai Bhimani currently holds 1 directorship: Narmada Life Line Multispeciality Hospital Llp (Designated Partner, since 21 May 2025).

Jignesh Jaysukhbhai Bhimani was first appointed on 21 May 2025 as Designated Partner at Narmada Life Line Multispeciality Hospital Llp.

The current boards of Jignesh Jaysukhbhai Bhimani's companies include Chirag Ranchhodbhai Patel (Narmada Life Line Multispeciality Hospital Llp), Divyeshkumar Nareshbhai Savaj (Narmada Life Line Multispeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available